Our news

INNODIA moves to the next stage:
non-for-profit INNODIA iVZW established!

25. August 2022

On July 28th 2022 we established INNODIA iVZW, an international, non-profit organization, with its seat in Leuven, Belgium. The association is building further on what has been achieved within the INNODIA and INNODIA HARVEST IMI-JU funded projects. Founding members are the University of Leuven, King's College London, Medical University Graz, Hannoverische Kinderheilanstalt and Università degli Studii di Siena.
INNODIA iVZW provides a unique pan-European clinical trial infrastructure for type 1 diabetes (T1D), with as specific goals to:

  1. expand quality T1D clinical trial infrastructure
  2. provide expertise on smart clinical trial design
  3. optimize the use of data and samples from people with T1D and at risk individuals for biomarker analysis
  4. share expertise within the European T1D research space
  5. provide access to expert research and biomarker laboratories
  6. empower people living with T1D in clinical trials
  7. accelerate new entrants and innovation.

Be prepared to join us as member, as clinical trial center, as academic institution or as any other non-profit organization interested in T1D! More to come soon!

We are hiring!

INNODIA iVZW is recruiting a full-time Managing Director!